相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The mechanisms of anti-PEG immune response are different in the spleen and the lymph nodes
Philippe Grenier et al.
JOURNAL OF CONTROLLED RELEASE (2023)
In vivo HSC prime editing rescues sickle cell disease in a mouse model
Chang Li et al.
BLOOD (2023)
Disrupting the adult-globin promoter alleviates promoter competition and reactivates foetal-globin gene expression
Sarah Topfer et al.
BLOOD (2022)
Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs
Dhruva Katrekar et al.
NATURE BIOTECHNOLOGY (2022)
CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy
Cedric Happi Mbakam et al.
NEUROTHERAPEUTICS (2022)
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease
Julie Kanter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy
Jeong Pil Han et al.
SCIENCE ADVANCES (2022)
L-glutamine for sickle cell disease: more than reducing redox
Firas Jafri et al.
ANNALS OF HEMATOLOGY (2022)
A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease
Julia Z. Xu et al.
BLOOD (2022)
CRISPR/Cas9-based multiplex genome editing of BCL11A and HBG efficiently induces fetal hemoglobin expression
Yuanyuan Han et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2022)
Generation of CRISPR-Cas9-mediated genetic knockout human intestinal tissue-derived enteroid lines by lentivirus transduction and single-cell cloning
Shih-Ching Lin et al.
NATURE PROTOCOLS (2022)
New Advances in Using Virus-like Particles and Related Technologies for Eukaryotic Genome Editing Delivery
Pin Lyu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Natural Nucleoside Modifications in Guide RNAs Can Modulate the Activity of the CRISPR-Cas9 System In Vitro
Daria V. V. Prokhorova et al.
CRISPR JOURNAL (2022)
Versatile and efficient genome editing with Neisseria cinerea Cas9
Zhiquan Liu et al.
COMMUNICATIONS BIOLOGY (2022)
A Cancer Cell Membrane-Derived Biomimetic Nanocarrier for Synergistic Photothermal/Gene Therapy by Efficient Delivery of CRISPR/Cas9 and Gold Nanorods
Lin Huang et al.
ADVANCED HEALTHCARE MATERIALS (2022)
Optimizing CRISPR/Cas9 Editing of Repetitive Single Nucleotide Variants
Inga Usher et al.
FRONTIERS IN GENOME EDITING (2022)
Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic Kras(G12D) in pancreatic cancer
Kathleen M. McAndrews et al.
LIFE SCIENCE ALLIANCE (2021)
In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model
Chang Li et al.
MOLECULAR THERAPY (2021)
PLGA-Nanoparticles for Intracellular Delivery of the CRISPR-Complex to Elevate Fetal Globin Expression in Erythroid Cells
Luis J. Cruz et al.
BIOMATERIALS (2021)
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
H. Frangoul et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Benserazide as a potential novel fetal hemoglobin inducer: an observational study in non-carriers of hemoglobin disorders
Marina Ere Hummel Pimenta Santos et al.
BLOOD CELLS MOLECULES AND DISEASES (2021)
Voxelotor for the treatment of sickle cell disease
Madhav Vissa et al.
EXPERT REVIEW OF HEMATOLOGY (2021)
Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice
Adam C. Wilkinson et al.
NATURE COMMUNICATIONS (2021)
Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models
Chady H. Hakim et al.
NATURE COMMUNICATIONS (2021)
Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease
Naoya Uchida et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
DNA Repair Pathway Choices in CRISPR-Cas9-Mediated Genome Editing
Chaoyou Xue et al.
TRENDS IN GENETICS (2021)
; ); ); );
Jo Howard et al.
LANCET HAEMATOLOGY (2021)
Points of View on the Tools for Genome/Gene Editing
Chin-Kai Chuang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
RNA splicing modulation: Therapeutic progress and perspectives
Amel Saoudi et al.
M S-MEDECINE SCIENCES (2021)
Base editing of haematopoietic stem cells rescues sickle cell disease in mice
Gregory A. Newby et al.
NATURE (2021)
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Julian D. Gillmore et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease
Annalisa Lattanzi et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Potential of helper-dependent Adenoviral vectors in CRISPR-cas9-mediated lung gene therapy
Ranmal Avinash Bandara et al.
CELL AND BIOSCIENCE (2021)
A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation
Yu Zhang et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
Matthew Behr et al.
ACTA PHARMACEUTICA SINICA B (2021)
Efficient Peptide-Mediated In Vitro Delivery of Cas9 RNP
Oskar Gustafsson et al.
PHARMACEUTICS (2021)
Preclinical evaluation for engraftment of CD34+ cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate models
Naoya Uchida et al.
CELL REPORTS MEDICINE (2021)
Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency
Cheng-Han Chung et al.
MOLECULAR THERAPY (2020)
Sickle-Cell Disease Co-Management, Health Care Utilization, and Hydroxyurea Use
Nancy Crego et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2020)
Aptamer/Peptide-Functionalized Genome-Editing System for Effective Immune Restoration through Reversal of PD-L1-Mediated Cancer Immunosuppression
Xiao-Yan He et al.
ADVANCED MATERIALS (2020)
Development of gene editing strategies for human β-globin (HBB) gene mutations
Batuhan Mert Kalkan et al.
GENE (2020)
Trends in Sickle Cell Disease-Related Mortality in the United States, 1979 to 2017
Amanda B. Payne et al.
ANNALS OF EMERGENCY MEDICINE (2020)
Comparative targeting analysis of KLF1, BCL11A, and HBG1/2 in CD34+ HSPCs by CRISPR/Cas9 for the induction of fetal hemoglobin
Andres Lamsfus-Calle et al.
SCIENTIFIC REPORTS (2020)
Electroporation and genetic supply of Cas9 increase the generation efficiency of CRISPR/Cas9 knock-in alleles in C57BL/6J mouse zygotes
Samy Alghadban et al.
SCIENTIFIC REPORTS (2020)
Supramolecular nanosubstrate-mediated delivery system enables CRISPR-Cas9 knockin of hemoglobin beta gene for hemoglobinopathies
Peng Yang et al.
SCIENCE ADVANCES (2020)
Combined lentiviral- and RNA-mediated CRISPR/Cas9 delivery for efficient and traceable gene editing in human hematopoietic stem and progenitor cells
David Yudovich et al.
SCIENTIFIC REPORTS (2020)
Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease
Ifeyinwa Osunkwo et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2020)
Allosteric inhibition of CRISPR-Cas9 by bacteriophage-derived peptides
Yan-ru Cui et al.
GENOME BIOLOGY (2020)
Highly efficient therapeutic gene editing of human hematopoietic stem cells
Yuxuan Wu et al.
NATURE MEDICINE (2019)
Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous Recombination
Renata M. Martin et al.
CELL STEM CELL (2019)
Exosomes
D. Michiel Pegtel et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 88 (2019)
Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease
Mohammad Ali Khosravi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer
Man Li et al.
JOURNAL OF CONTROLLED RELEASE (2019)
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
Elliott Vichinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease
So Hyun Park et al.
NUCLEIC ACIDS RESEARCH (2019)
Gene Therapy Tools for Brain Diseases
Selene Ingusci et al.
FRONTIERS IN PHARMACOLOGY (2019)
Francisella novicida Cas9 interrogates genomic DNA with very high specificity and can be used for mammalian genome editing
Sundaram Acharya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Systematic Review of l-glutamine for Prevention of Vaso-occlusive Pain Crisis in Patients with Sickle Cell Disease
Nicole E. Cieri-Hutcherson et al.
PHARMACOTHERAPY (2019)
Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis
Abdullah Kutlar et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
A natural regulatory mutation in the proximal promoter elevates fetal globin expression by creating a de novo GATA1 site
Gabriella E. Martyn et al.
BLOOD (2019)
Guide RNA modification as a way to improve CRISPR/Cas9-based genome-editing systems
Julia Filippova et al.
BIOCHIMIE (2019)
CRISPR-Cas9 interrogation of a putative fetal globin repressor in human erythroid cells
Jennifer E. Chung et al.
PLOS ONE (2019)
Genome editing of HBG1 and HBG2 to induce fetal hemoglobin
Jean-Yves Metais et al.
BLOOD ADVANCES (2019)
The E3 ligase adaptor molecule SPOP regulates fetal hemoglobin levels in adult erythroid cells
Xianjiang Lan et al.
BLOOD ADVANCES (2019)
Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease
Deborah Lubeck et al.
JAMA NETWORK OPEN (2019)
A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease
Liuhong Cai et al.
STEM CELLS TRANSLATIONAL MEDICINE (2018)
Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus
Chiara Antoniani et al.
BLOOD (2018)
Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing
Chang Li et al.
BLOOD (2018)
Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch
Nan Liu et al.
CELL (2018)
Enhancement of red blood cell transfusion compatibility using CRISPR-mediated erythroblast gene editing
Joseph Hawksworth et al.
EMBO MOLECULAR MEDICINE (2018)
In Vivo Ovarian Cancer Gene Therapy Using CRISPR-Cas9
Zhi-Yao He et al.
HUMAN GENE THERAPY (2018)
Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding
Gabriella E. Martyn et al.
NATURE GENETICS (2018)
CRISPR/Cas9 genome editing in human hematopoietic stem cells
Rasmus O. Bak et al.
NATURE PROTOCOLS (2018)
Sickle cell disease
Gregory J. Kato et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
A Nonhuman Primate Transplantation Model to Evaluate Hematopoietic Stem Cell Gene Editing Strategies for beta-Hemoglobinopathies
Olivier Humbert et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Impact of anti-PEG antibodies on PEGylated nanoparticles fate in vivo
Kinam Park
JOURNAL OF CONTROLLED RELEASE (2018)
Large deletions induced by Cas9 cleavage
Fatwa Adikusuma et al.
NATURE (2018)
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
Christopher A. Vakulskas et al.
NATURE MEDICINE (2018)
Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with beta-Thalassemia Major
Nikoletta Psatha et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Stearyl polyethylenimine complexed with plasmids as the core of human serum albumin nanoparticles noncovalently bound to CRISPR/Cas9 plasmids or siRNA for disrupting or silencing PD-L1 expression for immunotherapy
Wei-Jie Cheng et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Gene Therapy in a Patient with Sickle Cell Disease
Jean-Antoine Ribeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Genome Editing for Cancer Therapy: Delivery of Cas9 Protein/sgRNA Plasmid via a Gold Nanocluster/Lipid Core-Shell Nanocarrier
Peng Wang et al.
ADVANCED SCIENCE (2017)
Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing inBone-Marrow-Derived CD34+ Hematopoietic Stem and Progenitor Cells
Kai-Hsin Chang et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Relationship between Mixed Donor-Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell Disease
Allistair Abraham et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review
Joep W. R. Sins et al.
BLOOD ADVANCES (2017)
Adherence to hydroxyurea medication by children with sickle cell disease (SCD) using an electronic device: a feasibility study
Susumu Inoue et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Genetic disruption of the KLF1 gene to overexpress the -globin gene using the CRISPR/Cas9 system
Laleh Shariati et al.
JOURNAL OF GENE MEDICINE (2016)
Programmed Self-Assembly of an Active P22-Cas9 Nanocarrier System
Shefah Qazi et al.
MOLECULAR PHARMACEUTICS (2016)
CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells
Megan D. Hoban et al.
MOLECULAR THERAPY (2016)
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Daniel P. Dever et al.
NATURE (2016)
A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition
Elizabeth A. Traxler et al.
NATURE MEDICINE (2016)
Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia
Lin Ye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Defining Sickle Cell Disease Mortality Using a Population-Based Surveillance System, 2004 through 2008
Susan T. Paulukonis et al.
PUBLIC HEALTH REPORTS (2016)
Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin
Takeshi Masuda et al.
SCIENCE (2016)
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
Mark A. DeWitt et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Insulin-Like Growth Factor-Binding Protein-7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction Results From the RELAX Trial
Parul U. Gandhi et al.
JACC-HEART FAILURE (2016)
Novel HDAd/EBV Reprogramming Vector and Highly Efficient Ad/CRISPR-Cas Sickle Cell Disease Gene Correction
Chao Li et al.
SCIENTIFIC REPORTS (2016)
The Potential of the Combination of CRISPR/Cas9 and Pluripotent Stem Cells to Provide Human Organs from Chimaeric Pigs
Wanyou Feng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
Matthew C. Canver et al.
NATURE (2015)
Therapeutic genome editing: prospects and challenges
David Benjamin Turitz Cox et al.
NATURE MEDICINE (2015)
Good things come in small packages: exosomes, immunity and cancer
W. Wang et al.
CANCER GENE THERAPY (2014)
Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-Thalassemia and Sickle Cell Disease
Olivier Negre et al.
CURRENT GENE THERAPY (2014)
Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins
Sojung Kim et al.
GENOME RESEARCH (2014)
Gold Nanoparticles for Nucleic Acid Delivery
Ya Ding et al.
MOLECULAR THERAPY (2014)
Unravelling the structural and mechanistic basis of CRISPR-Cas systems
John van der Oost et al.
NATURE REVIEWS MICROBIOLOGY (2014)
National Trends in Hospitalizations for Sickle Cell Disease in the United States Following the FDA Approval of Hydroxyurea, 1998-2008
Maureen M. Okam et al.
MEDICAL CARE (2014)
Long-Term Outcome and Evaluation of Organ Function in Pediatric Patients Undergoing Haploidentical and Matched Related Hematopoietic Cell Transplantation for Sickle Cell Disease
Mari H. Dallas et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Immune responses to AAV vectors: overcoming barriers to successful gene therapy
Federico Mingozzi et al.
BLOOD (2013)
One-Step Generation of Mice Carrying Reporter and Conditional Alleles by CRISPR/Cas-Mediated Genome Engineering
Hui Yang et al.
CELL (2013)
Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates
Frederic B. Piel et al.
LANCET (2013)
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
Yanfang Fu et al.
NATURE BIOTECHNOLOGY (2013)
Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders
Daniel E. Bauer et al.
BLOOD (2012)
Prevalence of Hemoglobinopathy Disorders in Adult Patients Sent for Diagnosis of Anemia in Saudi Arabia
Abbas H. Alsaeed
GENETIC TESTING AND MOLECULAR BIOMARKERS (2012)
Umbilical Cord Blood Transplantation for Children with Thalassemia and Sickle Cell Disease
Annalisa Ruggeri et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L
Bart R. Anderson et al.
NUCLEIC ACIDS RESEARCH (2011)
Population Estimates of Sickle Cell Disease in the US
Kathryn L. Hassell
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2010)
Endosome-Disruptive Peptides for Improving Cytosolic Delivery of Bioactive Macromolecules
Ikuhiko Nakase et al.
BIOPOLYMERS (2010)
Sickle Cell Disease: An Opportunity for Palliative Care Across the Life Span
Diana J. Wilkie et al.
NURSING CLINICS OF NORTH AMERICA (2010)
Beta-thalassemia
Renzo Galanello et al.
ORPHANET JOURNAL OF RARE DISEASES (2010)
HIV-1 derived peptides fused to HBsAg affect its immunogenicity
Minerva Cervantes Gonzalez et al.
VIRUS RESEARCH (2009)
Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease
Francoise Bernaudin et al.
BLOOD (2007)
Control of globin gene expression during development and erythroid differentiation
G Stamatoyannopoulos
EXPERIMENTAL HEMATOLOGY (2005)
Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease
LS Kean et al.
BLOOD (2003)
Identification of genes that are associated with DNA repeats in prokaryotes
R Jansen et al.
MOLECULAR MICROBIOLOGY (2002)
Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model
A Auricchio et al.
HUMAN MOLECULAR GENETICS (2001)
A peptide carrier for the delivery of biologically active proteins into mammalian cells
MC Morris et al.
NATURE BIOTECHNOLOGY (2001)
Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia
MC Walters et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
分享论文
